Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia.

J Adv Pract Oncol

Georgia Regents Medical Center, Augusta, Georgia, and University of Georgia College of Pharmacy, Augusta, Georgia.

Published: December 2015

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677809PMC
http://dx.doi.org/10.6004/jadpro.2015.6.4.7DOI Listing

Publication Analysis

Top Keywords

obinutuzumab novel
4
novel anti-cd20
4
anti-cd20 monoclonal
4
monoclonal antibody
4
antibody chronic
4
chronic lymphocytic
4
lymphocytic leukemia
4
obinutuzumab
1
anti-cd20
1
monoclonal
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!